Non‐severe immunosuppression might be associated with a lower risk of moderate–severe acute respiratory distress syndrome in COVID‐19: A pilot study
Enric Monreal(Hospital Universitario Ramón y Cajal), Elena Natera‐Villalba(Universidad de Alcalá), Beatriz Montero‐Errasquín(Universidad de Alcalá), Jaime Masjuán(Universidad de Alcalá), Juan Luis Chico‐García(Universidad de Alcalá), Álvaro Beltrán‐Corbellini(Universidad de Alcalá), Nuria García‐Barragán(Instituto Cajal), Javier Buisán(Instituto Cajal), Íñigo Corral(Hospital Universitario Ramón y Cajal), Rafael Toledano(Hospital Ruber Internacional), Javier Martínez‐Sanz(Instituto de Salud Carlos III), Lucienne Costa‐Frossard(Universidad de Alcalá), Pedro Gullón(Universidad de Alcalá), Luís Manzano(Universidad de Alcalá), Paula Pérez‐Torre(Hospital Universitario Ramón y Cajal), Araceli Alonso‐Cánovas(Universidad de Alcalá), María Consuelo Matute-Lozano(Instituto Cajal), José Luis López-Sendón(Hospital Universitario Ramón y Cajal), Guillermo García‐Ribas(Instituto Ramón y Cajal de Investigación Sanitaria), Sainz de la Maza S(Universidad de Alcalá), Jesús Fortün(Evidence (Italy)), Luis Máiz‐Carro(Universidad de Alcalá)
Cited by 11
Related Papers
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|823
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials
|European Heart Journal|2017|643
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
|The Lancet HIV|2020|396